We called it! Say hello to at-home NAD and peptide injection pens. YPulse predicted NAD+ would be 2026’s super drug obsession, “becoming normalized, optimized, and packaged for everyday use.” The brand Remedy Place, which currently offers the now-popular vitamin, peptide, and NAD IV drips and shots at their physical locations, is aiming to make that happen by giving customers a way to keep up their regimen on their own. Because at-home NAD injections require a prescription in the U.S., the “smart pens” are being produced in the U.K., where injectables are nominally easier to access. Remedy Place won’t be advertising these injection pens traditionally though—they want to rely on social media and e-mail notices to their existing followers and spreading from there through organic word of mouth. (Glossy)
👀 Read more from YPulse: 5 Bonus YPulse Predictions for 2026
